# Metagenomi, Inc. Common Stock (MGX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MGX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 991.0K | $ -50.54M | $ -40.84M | $ 37.72M | $ 112.57M |
| 2025 | $ 25.81M | $ -89.97M | $ -91.61M | $ 40.66M | $ 158.60M |
| 2024 | $ 54.97M | $ -82.05M | $ -117.92M | $ 45.78M | $ 234.86M |
| 2023 | $ 48.39M | $ -73.80M | $ -109.45M | $ 48.23M | $ -135.58M |
| 2022 | $ 19.21M | $ -48.70M | $ 17.59M | $ 18.57M | $ -74.43M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.34 |
| Liabilities / Eq | 0.54 |
| Current Ratio | 4.50 |

## Other views

- [Metrics](https://sponda.capital/en/MGX.md)
- [Charts](https://sponda.capital/en/MGX/charts.md)
- [Compare](https://sponda.capital/en/MGX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.